Pediatrix Medical Group, Inc. MD
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 487.78M | 476.20M | 493.77M | 492.88M | 468.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 487.78M | 476.20M | 493.77M | 492.88M | 468.84M |
| Cost of Revenue | 355.31M | 363.23M | 367.79M | 352.53M | 344.12M |
| Gross Profit | 132.47M | 112.96M | 125.98M | 140.35M | 124.73M |
| SG&A Expenses | 61.29M | 60.27M | 65.68M | 60.79M | 55.71M |
| Depreciation & Amortization | 5.78M | 6.12M | 5.63M | 5.55M | 5.31M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 422.39M | 429.62M | 439.10M | 418.87M | 405.14M |
| Operating Income | 65.40M | 46.58M | 54.67M | 74.01M | 63.70M |
| Income Before Tax | 54.00M | 38.84M | 45.60M | 87.78M | 54.97M |
| Income Tax Expenses | 14.16M | 9.27M | 11.91M | 16.07M | 15.71M |
| Earnings from Continuing Operations | 39.84M | 29.57M | 33.68M | 71.71M | 39.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.84M | 29.57M | 33.68M | 71.71M | 39.26M |
| EBIT | 65.40M | 46.58M | 54.67M | 74.01M | 63.70M |
| EBITDA | 71.18M | 52.70M | 60.30M | 79.56M | 69.01M |
| EPS Basic | 0.50 | 0.37 | 0.40 | 0.85 | 0.46 |
| Normalized Basic EPS | 0.49 | 0.34 | 0.38 | 0.54 | 0.43 |
| EPS Diluted | 0.49 | 0.36 | 0.40 | 0.84 | 0.46 |
| Normalized Diluted EPS | 0.48 | 0.33 | 0.38 | 0.53 | 0.43 |
| Average Basic Shares Outstanding | 79.44M | 80.88M | 84.42M | 84.61M | 84.80M |
| Average Diluted Shares Outstanding | 81.41M | 83.08M | 84.42M | 85.61M | 85.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |